122 related articles for article (PubMed ID: 14582056)
1. Reactivity of iron compounds.
Geisser P
Am J Kidney Dis; 2003 Nov; 42(5):1103-4. PubMed ID: 14582056
[No Abstract] [Full Text] [Related]
2. Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients.
Hörl WH
Perit Dial Int; 2001; 21(5):527-8. PubMed ID: 11757843
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics and utilization of iron sucrose.
Danielson BG; Beshara S
Am J Kidney Dis; 2003 Nov; 42(5):1104; author reply 1104-5. PubMed ID: 14582057
[No Abstract] [Full Text] [Related]
4. Safety issues with iron sucrose.
Fishbane S
Am J Kidney Dis; 2003 Apr; 41(4):899; author reply 900. PubMed ID: 12666081
[No Abstract] [Full Text] [Related]
5. Staining of fungi with saccharated iron oxide.
CIBIS PA; YAMASHITA T
Stain Technol; 1959 May; 34(3):129-33. PubMed ID: 13659241
[No Abstract] [Full Text] [Related]
6. Staining of the retina with saccharated iron oxide.
YAMASHITA T; CIBIS PA
AMA Arch Ophthalmol; 1959 May; 61(5):698-708. PubMed ID: 13636564
[No Abstract] [Full Text] [Related]
7. Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations.
NISSIM JA
Br Med J; 1954 Feb; 1(4858):352-6. PubMed ID: 13115719
[No Abstract] [Full Text] [Related]
8. [A growth media of genus Legionella in containing saccharated ferric oxide (Fesin) replacing soluble ferric pyrophosphate (author's transl)].
Tanaka H; Nagasawa M; Ito N; Fujita I; Shigeno Y; Yamaguchi K; Hirota M; Nakatomi M; Nasu M; Saito A; Hara K
Kansenshogaku Zasshi; 1982 Mar; 56(3):175-81. PubMed ID: 6809855
[No Abstract] [Full Text] [Related]
9. The immediate hematologic effects of intravenous saccharated iron oxide.
WHITE LP; BIERMAN HR; KELLY KH; BYRON RL
Blood; 1952 Sep; 7(9):897-903. PubMed ID: 14953947
[No Abstract] [Full Text] [Related]
10. DISTRIBUTION OF INTRAVENOUSLY ADMINISTERED SACCHARATED IRON OXIDE IN THE POPLITEAL LYMPH NODE OF THE RABBIT.
MENZIES DW; RYAN GB
Nature; 1964 Jul; 203():309-10. PubMed ID: 14201777
[No Abstract] [Full Text] [Related]
11. Enhancing effect of saccharated ferric oxide on human lymphocyte transformation in serum-free medium.
Tanno Y; Takishima T
Tohoku J Exp Med; 1982 Apr; 136(4):463-4. PubMed ID: 7101280
[TBL] [Abstract][Full Text] [Related]
12. The cellular transformation of injected colloidal iron complexes into ferritin and hemosiderin in experimental animals; a study with the aid of electron microscopy.
RICHTER GW
J Exp Med; 1959 Feb; 109(2):197-216. PubMed ID: 13620849
[TBL] [Abstract][Full Text] [Related]
13. Intravenous iron: evaluation of the use of saccharated iron oxide in iron deficiency states in obstetrics and gynecology.
HOLLY RG
Blood; 1951 Nov; 6(11):1159-72. PubMed ID: 14869375
[No Abstract] [Full Text] [Related]
14. [Dextran-ferrite distribution in the body of animals in a nonuniform permanent magnetic field].
Syrkin AB; Iushkov SF; Bulychev IuN; Brusentsov NA; Osipov NE; Karamanov SA; Kolesnikova EIu
Eksp Onkol; 1990; 12(5):71-3. PubMed ID: 2226266
[TBL] [Abstract][Full Text] [Related]
15. Intravenous treatment of anaemia with an iron-sucrose preparation.
SLACK HG; WILKINSON JF
Lancet; 1949 Jan; 1(6540):11-4. PubMed ID: 18208026
[No Abstract] [Full Text] [Related]
16. Labile iron in parenteral iron formulations: a quantitative and comparative study.
Van Wyck D; Anderson J; Johnson K
Nephrol Dial Transplant; 2004 Mar; 19(3):561-5. PubMed ID: 14767009
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence decision for nanoparticular iron complex drugs for parenteral administration based on their disposition.
Schnorr J; Fütterer S; Spicher K; Catarinolo M; Schlösser C; Enzmann H; Langguth P
Regul Toxicol Pharmacol; 2018 Apr; 94():293-298. PubMed ID: 29454888
[TBL] [Abstract][Full Text] [Related]
18. Iron sucrose or ferric gluconate?
Duffy CI
Am J Kidney Dis; 2001 Dec; 38(6):1442. PubMed ID: 11728988
[No Abstract] [Full Text] [Related]
19. Safety of high doses of non-dextran irons.
Folkert VW
Semin Dial; 2003; 16(3):285-6. PubMed ID: 12753696
[No Abstract] [Full Text] [Related]
20. Hypophosphatemia induced by intravenous administration of Saccharated iron oxide.
Okada M; Imamura K; Iida M; Fuchigami T; Omae T
Klin Wochenschr; 1983 Jan; 61(2):99-102. PubMed ID: 6843038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
